MedPath

Evaluation of neuroprotective effect of Resveratrol during acute ischemic stroke on neurologic deficit

Phase 3
Conditions
Ischemic stroke.
Cerebral infarction
Registration Number
IRCT2016061328430N1
Lead Sponsor
Vice chancellor for research, Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Age between 45 and 90 years; Diagnosis of ischemic stroke in MCA territory
Exclusion criteria: Pregnancy; Referral of the patient for more than 24 hours after start of symptoms; Patients who have received RtPA; Brain hemorrhage and previous stroke.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Before the start of the study, upon discharge and three months after the discharge. Method of measurement: Using the barometer device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath